8STG
Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X06SA |
Synchrotron site | SLS |
Beamline | X06SA |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2020-09-01 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 1.000032 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 62.510, 91.340, 129.620 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 56.300 - 3.790 |
R-factor | 0.3073 |
Rwork | 0.307 |
R-free | 0.31060 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3ri1 |
RMSD bond length | 0.006 |
RMSD bond angle | 0.733 |
Data reduction software | autoPROC |
Data scaling software | autoPROC |
Phasing software | PHASER |
Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 56.305 | 3.852 |
High resolution limit [Å] | 3.787 | 3.787 |
Rmerge | 0.123 | 1.742 |
Number of reflections | 7810 | 383 |
<I/σ(I)> | 4.3 | |
Completeness [%] | 99.8 | 99.7 |
Redundancy | 9.56 | |
CC(1/2) | 0.982 | 0.615 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 291.15 | 0.1 M Tris, pH 8, 18-20% w/v PEG8000 |